Seyedifar, Meysam, Fatemi, Behzad, Soleymani, Fatemeh, Sabouri, Menhajuddin. (1403). Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis. سامانه مدیریت نشریات علمی, (), -. doi: 10.30476/mejc.2024.100077.1969
Meysam Seyedifar; Behzad Fatemi; Fatemeh Soleymani; Menhajuddin Sabouri. "Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis". سامانه مدیریت نشریات علمی, , , 1403, -. doi: 10.30476/mejc.2024.100077.1969
Seyedifar, Meysam, Fatemi, Behzad, Soleymani, Fatemeh, Sabouri, Menhajuddin. (1403). 'Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis', سامانه مدیریت نشریات علمی, (), pp. -. doi: 10.30476/mejc.2024.100077.1969
Seyedifar, Meysam, Fatemi, Behzad, Soleymani, Fatemeh, Sabouri, Menhajuddin. Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis. سامانه مدیریت نشریات علمی, 1403; (): -. doi: 10.30476/mejc.2024.100077.1969


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب